Delivery Order SPE2DB22D9353-SPE2DB25FX1YM
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $18,488.12 by the Defense Logistics Agency (DLA) for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The award, issued on July 26, 2025, with an ultimate completion date of July 28, 2025, carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a firm fixed-price delivery order valued at $18,488.12 from the Defense Logistics Agency (DLA) on September 12, 2025. The delivery order, which is expected to be completed by September 15, 2025, covers the supply of Trikafta 100-50-75 mg/150 mg tablets in a quantity of 84 units. This award was issued without a set-aside designation, allowing DMS Pharmaceutical Group to...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $18,488.12 by the Defense Logistics Agency (DLA) on June 18, 2025, with an ultimate completion date of June 20, 2025. This delivery order, identified as 4568601968, is for the supply of Trikafta 100-50-75 mg/150 mg tablets in quantities of 84 units. The award was made without a set-aside designation, allowing the vendor to...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $18,488.12 by the Defense Logistics Agency (DLA) for Trikafta 100-50-75 mg/150 mg tablets. This firm fixed-price delivery order, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a direct fulfillment of pharmaceutical supply needs for federal healthcare systems. The award carries no set-aside...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at approximately $37,000 by the Defense Logistics Agency on August 25, 2025, for the supply of Trikafta 100-50-75 mg/150 mg pharmaceutical product. This firm fixed-price delivery order, with an ultimate completion date of August 26, 2025, was issued without a set-aside designation and represents a continuation of DMS Pharmaceutical Group's...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $56,290.43 by the Defense Logistics Agency (DLA) on June 27, 2025, with an ultimate completion date of June 30, 2025. The delivery order, issued without a set-aside designation, is for Trikafta 100-50-75 mg/150 mg pharmaceutical product (84 units), with performance occurring in Park Ridge, Illinois. This award represents a...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $18,488.12 by the Defense Logistics Agency on September 8, 2025, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The delivery order carries an ultimate completion date of September 9, 2025, and represents no set-aside designation. This award falls under DMS Pharmaceutical Group's larger Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $18,488.12 by the Defense Logistics Agency (DLA) on July 14, 2025. The delivery order, which is scheduled for completion by July 15, 2025, covers the supply of Trikafta 100-50-75 mg/150 mg tablets in a quantity of 84 units. This award was issued without set-aside designation and represents a single delivery order under DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $18,488.12 by the Defense Logistics Agency on August 5, 2025. The delivery order, which expires August 6, 2025, is for Trikafta 100-50-75 mg/150 mg pharmaceutical products. This award was issued without a set-aside designation and represents a single delivery order under DMS Pharmaceutical Group's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a $55,580.49 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order, issued under DLA's SPE2DB Pharmaceutical Prime Vendor program, is to provide the pharmaceutical product Trikafta 100-50-75 mg/150 mg with an ultimate completion date of July 12, 2024. DMS Pharmaceutical Group holds a large, single-award indefinite delivery contract...
- SPE2DB22D9353Indefinite Delivery Contract
- SPE2DB22D9353-SPE2DB25FX1YMDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $117,065.98 by the Defense Logistics Agency (DLA) on June 25, 2025. The delivery order, which has an ultimate completion date of June 26, 2025, is for the supply of Trikafta 100-50-75 mg/150 mg tablets in a quantity of 84 units. This award was issued without a set-aside designation, allowing the contractor to compete on an unrestricted basis. The delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a single-award vehicle valued at $499,999,999 and valid through November 2026. The SPE2DB contract enables the DLA to procure a comprehensive range of pharmaceutical products and medical supplies to support Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group's role as a prime contractor on this vehicle positions it as a critical supplier within the federal pharmaceutical supply chain, providing branded and generic prescription drugs, biologics, and medical consumables directly to military health facilities. The company's successful track record with the DLA, demonstrated through numerous prior delivery orders for specialty medications and pharmaceutical products, underscores its established capability to meet federal healthcare procurement requirements efficiently and reliably.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $117.1k | 6/25/25 |